| Tentolouris N, Voulgari C, Katsilambros N
A review of nateglinide in the management of patients with type 2 diabetes. [Journal Article]
Vasc Health Risk Manag 2007; 3(6):797-807.
Abstract | Full Citation |
| González-Ortiz M, Hernández-Salazar E, Martínez-Abundis E
Effect of the administration of a single dose of nateglinide on insulin secretion at two different concentrations of glucose in healthy individuals. [Journal Article, Randomized Controlled Trial]
J Diabetes Complications 2005 Nov-Dec; 19(6):356-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Campbell IW
Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus. [Journal Article, Review]
Int J Clin Pract 2005 Oct; 59(10):1218-28.
Abstract | Full Citation | Find Related Articles |
| Pari L, Ashokkumar N
Effect of N-benzoyl-D-phenylalanine, a new potential oral antidiabetic agent, in neonatal streptozotocin-induced diabetes in rats. [Journal Article]
Pharmacol Rep 2005 Jul-Aug; 57(4):498-503.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Oguri S, Nomura M, Fujita Y
A new strategy for the selective determination of D-amino acids: enzymatic and chemical modifications for pre-column derivatization. [Journal Article, Validation Studies]
J Chromatogr A 2005 Jun 17; 1078(1-2):51-8.
Abstract | Full Citation | Find Related Articles |
| Ozawa H, Murai Y, Ozawa T
[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus] [Historical Article, Journal Article]
Yakushigaku Zasshi 2003; 38(1):11-27.
Abstract | Full Citation | Find Related Articles |
| Chandrasekharan S, Rao PP, Jayaram S, et al.
Efficacy and safety of nateglinide in the treatment of type II diabetes mellitus. [Clinical Trial, Evaluation Studies, Journal Article, Multicenter Study]
J Indian Med Assoc 2002 Jul; 100(7):467-8.
Abstract | Full Citation | Find Related Articles |
| Hu S, Boettcher BR, Dunning BE
The mechanisms underlying the unique pharmacodynamics of nateglinide. [Journal Article, Review]
Diabetologia 2003 Mar.:M37-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Chachin M, Yamada M, Fujita A, et al.
Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels. [Journal Article]
J Pharmacol Exp Ther 2003 Mar; 304(3):1025-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hu S, Wang S, Dunning BE
Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide. [Journal Article]
Int J Exp Diabetes Res 2001; 2(1):63-72.
Abstract | Full Citation | Find Related Articles |
  |
New! 